Evidence map›Paper›PMID 34291113›Full record

ArticleERJ open research2021

Clinical and research priorities for children and young people with bronchiectasis: an international roadmap.

Anne B Chang, Jeanette Boyd, Leanne Bell, Vikas Goyal, I Brent Masters, Zena Powell, Christine Wilson, Angela Zacharasiewicz, Efthymia Alexopoulou, Andrew Bush and 11 more

Abstract read
In one paragraph

Article in ERJ open research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Mucolytics for children with chronic suppurative lung disease.The Cochrane database of systematic reviews · 2025
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Pediatric Bronchiectasis: Priorities, Precision Medicine, and Transition to Adult Care.American journal of respiratory and critical care medicine · 2024
    Article
  11. Article
  12. Article
  13. Global respiratory health priorities at the beginning of the 21st century.European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
  14. Review
  15. Can microbiologists and infectious diseases physicians contribute to the management of bronchiectasis? A view from Down Under.Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Anne B ChangAustralian Centre for Health Services Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.ORCID https://orcid.org/0000-0002-1331-3706
Jeanette BoydEuropean Lung Foundation, Sheffield, UK.
Leanne BellEuropean Lung Foundation Bronchiectasis Paediatric Patient Advisory Group, Sheffield, UK.
Vikas GoyalAustralian Centre for Health Services Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.ORCID https://orcid.org/0000-0001-7533-2315
I Brent MastersAustralian Centre for Health Services Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.
Zena PowellEuropean Lung Foundation Bronchiectasis Paediatric Patient Advisory Group, Sheffield, UK.
Christine WilsonDept of Physiotherapy, Queensland Children's Hospital, Brisbane, Queensland, Australia.
Angela ZacharasiewiczDept of Pediatrics and Adolescent Medicine, Teaching Hospital of the University of Vienna, Wilhelminen Hospital, Vienna, Austria.ORCID https://orcid.org/0000-0002-0511-2138
Efthymia Alexopoulou2nd Radiology Dept, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece.ORCID https://orcid.org/0000-0001-8466-4127
Andrew BushDept of Paediatric Respiratory Medicine, Royal Brompton Hospital, and National Heart and Lung Institute, Imperial School of Medicine, London, UK.
James D ChalmersCollege of Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK.
Rebecca FortescuePopulation Health Research Institute, St George's University of London, London, UK.
Adam T HillDept of Respiratory Medicine, Royal Infirmary and University of Edinburgh, Edinburgh, UK.
Bulent KaradagDivision of Pediatric Pulmonology, Marmara University Faculty of Medicine, Istanbul, Turkey.
Fabio MidullaDept of Maternal Science, Sapienza University of Rome, Rome, Italy.ORCID https://orcid.org/0000-0001-7476-5266
Gabrielle B McCallumChild Health Division, Menzies School of Health Research, Darwin, Northern Territory, Australia.ORCID https://orcid.org/0000-0002-0210-1468
Deborah SnijdersDolomiti Local Health and Social Unit, Belluno, Veneto, Italy.
Woo-Jung SongDept of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Thomy ToniaInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Keith GrimwoodDepts of Infectious Disease and Paediatrics, Gold Coast Health, Southport, Queensland, Australia.
Ahmad KantarPediatric Asthma and Cough Centre, Istituti Ospedalieri Bergamaschi, University and Research Hospitals, Ponte San Pietro, Bergamo, Italy.ORCID https://orcid.org/0000-0002-3445-4612

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The global burden of children and young people (CYP) with bronchiectasis is being recognised increasingly. They experience a poor quality of life and recurrent respiratory exacerbations requiring additional treatment, including hospitalisation. However, there are no published data on patient-driven clinical needs and/or research priorities for paediatric bronchiectasis. Parent/patient-driven views are required to understand the clinical needs and research priorities to inform changes that benefit CYP with bronchiectasis and reduce their disease burden. The European Lung Foundation and the European Respiratory Society Task Force for paediatric bronchiectasis created an international roadmap of clinical and research priorities to guide, and as an extension of, the clinical practice guideline. This roadmap was based on two global web-based surveys. The first survey (10 languages) was completed by 225 respondents (parents of CYP with bronchiectasis and adults with bronchiectasis diagnosed in childhood) from 21 countries. The parent/patient survey encompassed both clinical and research priorities. The second survey, completed by 258 health practitioners from 54 countries, was limited to research priorities. The two highest clinical needs expressed by parents/patients were: having an action management plan for flare-ups/exacerbations and access to physiotherapists. The two highest health practitioners' research priorities related to eradication of airway pathogens and optimal airway clearance techniques. Based on both surveys, the top 10 research priorities were derived, and unanimous consensus statements were formulated from these priorities. This document addresses parents'/patients' clinical and research priorities from both the parents'/patients' and clinicians' perspectives and will help guide research and clinical efforts to improve the lives of people with bronchiectasis.

Identifiers

PMID34291113
PMCPMC8287136

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.